Dexmedetomidine Hydrochloride Injection — FDA Drug Shortage

Current — Amneal Pharmaceuticals

The FDA lists a drug shortage record for Dexmedetomidine Hydrochloride Injection (injection) from Amneal Pharmaceuticals with status Current. The shortage was first posted on Apr 10, 2020.

Shortage details

Status
Current
Company
Amneal Pharmaceuticals
Package NDC
70121-1388-8
Dosage Form
Injection
Presentation
Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 70121-1388-8)
Initial Posting
Apr 10, 2020

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.